Related Experiment Video

Updated: Jul 20, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

[Multiple sclerosis: positive diagnosis]

Jérôme de Seze1, Christian Confavreux

  • 1Clinique neurologique, hôpital civil, 67091 Strasbourg. jerome.de.seze@chru-strasbourg.fr

La Revue Du Praticien
|September 5, 2006
PubMed

Insights

Diagnosing multiple sclerosis (MS) now uses magnetic resonance imaging (MRI) to confirm inflammatory events over time and space. This allows for a much earlier and more accurate MS diagnosis.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Context:

  • The established diagnosis of multiple sclerosis (MS) relies on demonstrating inflammatory central nervous system (CNS) events across both time and space.
  • Clinical and paraclinical evidence has traditionally been used for MS diagnosis.

Purpose:

  • To evaluate the utility of recently proposed diagnostic criteria for MS that incorporate magnetic resonance imaging (MRI) findings.
  • To determine if these new criteria facilitate earlier MS diagnosis.

Summary:

  • The proposed criteria leverage MRI data to define the dissemination in time and space of CNS inflammatory episodes, a key diagnostic requirement for MS.
  • Inclusion of MRI findings in the diagnostic criteria enhances the ability to confirm MS.

Impact:

  • These updated criteria enable a significantly earlier diagnosis of multiple sclerosis.
  • Facilitating early diagnosis can lead to prompt treatment initiation and potentially alter disease progression.

More Related Videos

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...